Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-28
1998-05-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514304, 514316, 514317, 514318, 514323, 544333, 546125, 546126, 546186, 546187, C07D21114, C07D23526, C07D23926, A61K 31415
Patent
active
057565082
ABSTRACT:
This invention is concerned with novel olones, derivatives thereof, their preparation, method of use and pharmaceutical compositions. These compounds are endowed with antimuscarinic activity and are useful in the treatment and/or prevention of myopia (commonly known as nearsightedness).
REFERENCES:
patent: 4066772 (1978-01-01), Vandenberk et al.
patent: 5122522 (1992-06-01), Laties et al.
patent: 5284843 (1994-02-01), Stone et al.
patent: 5574044 (1996-11-01), Thompson et al.
R. Feifel, et al., Br. J. Pharmacol. 99, pp. 455-460 (1990).
F. Dorje, et al., J. Pharmacol. and Exp. Thera., 256(2), pp. 727-733 (1991).
O. Cervinka and P. Malon, Chem. Commun., 42, pp (1977).
D. L. Commins and J. D. Brown, Tetra Ltrs., 27(38), pp. 4549-4552 (1986).
Mallorga Pierre
Ransom Richard W.
Sugrue Michael F.
Thompson Wayne J.
Ayler Sylvia A.
Daniel Mark R.
Merck & Co. , Inc.
Rao Deepak R.
Shah Mukund J.
LandOfFree
Muscarine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarine antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960364